CHAPTER 1. INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4. MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Rising demand for cell-based vaccines
4.1.2. Increasing corporate & government funding for cell-based research
4.1.3. Technological advancements
4.1.4. Widening application areas of microcarriers and increasing pharmaceutical R&D
expenditure
4.2. Market Restraints & Challenges
4.2.1. Separation process of microcarriers adds complexity
4.2.2. The high cost of cell biology
4.2.3. Ethical concerns regarding research on cell biology
4.2.4. Limitations in the production of high-density cell culture
4.3. Market Opportunities
4.3.1. Emerging countries to present high growth opportunities
CHAPTER 5. GLOBAL MICROCARRIER MARKET – BY PRODUCT
5.1. Equipment
5.1.1. Bioreactors
5.1.2. Culture Vessels
5.1.3. Filtration Systems
5.1.4. Cell Counters
5.1.4.1. Automated Cell Counters
5.1.4.2. Hemocytometers/Manual Cell Counters
5.1.5. Accessories
5.2. Consumables
5.2.1. Media
5.2.1.1. Serum-Free Media
5.2.1.2. Sera/Serum-Based Media
5.2.1.3. Others
5.2.2. Reagents
5.2.3. Microcarrier Beads
5.2.3.1. Cationic Microcarrier Beads
5.2.3.2. Collagen-Coated Microcarrier
5.2.3.3. Protein-Coated Microcarrier
5.2.3.4. Untreated Microcarrier Beads
CHAPTER 6. GLOBAL MICROCARRIER MARKET – BY APPLICATION
6.1. Cell Therapy
6.2. Vaccine Manufacturing
6.3. Others
CHAPTER 7. GLOBAL MICROCARRIER MARKET – BY END USER
7.1. Research Institutes
7.2. Pharmaceutical & Biotechnology Companies
7.3. Contract Research Organizations
CHAPTER 8. GLOBAL MICROCARRIER MARKET - BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.2.3. Mexico
8.2.4. Costa Rica
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Chile
8.3.4. Columbia
8.3.5. Others
8.4. Europe
8.4.1. U.K.
8.4.2. Germany
8.4.3. France
8.4.4. Italy
8.4.5. Spain
8.4.6. Russia
8.4.7. Netherlands
8.4.8. Switzerland
8.4.9. Poland
8.4.10. Others
8.5. APAC
8.5.1. China
8.5.2. Japan
8.5.3. India
8.5.4. South Korea
8.5.5. Australia & New Zealand
8.5.6. Malaysia
8.5.7. Singapore
8.5.8. Others
8.6. Middle East & Africa
8.6.1. UAE
8.6.2. Saudi Arabia
8.6.3. Iran
8.6.4. Iraq
8.6.5. Qatar
8.6.6. South Africa
8.6.7. Algeria
8.6.8. Morocco
8.6.9. Nigeria
8.6.10. Egypt
8.6.11. Others
CHAPTER 9. GLOBAL MICROCARRIER MARKET - COMPANY PROFILES
9.1. GE Healthcare
9.2. Thermo Fisher Scientific
9.3. Merck KGaA
9.4. Beckton, Dickson and Company
9.5. Eppendorf ag
9.6. HiMedia Laboratories Pvt. Ltd.
9.7. Sartorius AG
9.8. Danaher Corporation
9.9. Corning Inc.
9.10. Lonza Group
9.11. Siemens Healthnieers
9.12. F-Hoffmann La Roche AG
9.13. Abbott Laboratories
9.14. Sysmex Corporation
9.15. Horiba
CHAPTER 10. GLOBAL MICROCARRIER MARKET - COMPETITIVE LANDSCAPE
10.1. Market Share Analysis
10.2. Strategies adopted by top companies
10.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 11. MARKET INSIGHTS
11.1. Industry Experts Insights
11.2. Analysts Opinions
11.3. Investment Opportunities
CHAPTER 12. APPENDIX
12.1. List of Tables
12.2. List of Figures
